p16, Cyclin D1, and HIF-1α Predict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy

p16, Cyclin D1, and HIF-1α Predict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy

We evaluated a panel of 8 immunohistochemical biomarkers as predictors of clinical response to definitive intensity-modulated radiotherapy in patients with oropharyngeal squamous cell carcinoma (OPSCC). 106 patients with OPSCC were treated to a total dose of 66–70 Gy and retrospectively analyzed for...

Full description

Bibliographic Details
Main Authors: Asal S. Rahimi, David D. Wilson, Drew K. Saylor, Edward B. Stelow, Christopher Y. Thomas, James F. Reibel, Paul A. Levine, David C. Shonka, Mark J. Jameson, Paul W. Read
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:International Journal of Otolaryngology
Online Access:http://dx.doi.org/10.1155/2012/685951

Internet

http://dx.doi.org/10.1155/2012/685951

Similar Items